OTLK Shares -14.6% on 104M Volume After $0.01 EPS Miss
Finance and markets: Oncobiologics missed EPS by $0.01 and reported $0.01M revenue, yet 104M shares traded (6x volume) as insiders bought $5.16M; Galectin missed by $0.05.
Finance entity
Harold H. Shlevin
PersonEvery one of those 1 sits in a single category, earnings. Of the tracked stories, 1 of 1 also mention Faisal Ghiath Sukhtian, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.1 across the same-window beat baseline.
Last mentioned: 2h ago
Entity pulse
Recent coverage · Harold H. Shlevin
1 story
avg impact
0% positive
0% negative
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
What the coverage shows about Harold H. Shlevin
Every one of those 1 sits in a single category, earnings. Of the tracked stories, 1 of 1 also mention Faisal Ghiath Sukhtian, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.1 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 5.5 for that window. Harold H. Shlevin appears in 1 tracked Finance story from August 16, 2026.
- Stories tracked
- 1
- Sources per story
- 2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 32 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Harold H. Shlevin. Shared-story counts are live from our verified record — not editorial picks.
Stories mentioning Harold H. Shlevin 1
Harold H. Shlevin is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.